Of 12,134 patient specimens tested, 2,874 (23.7%) were virologically confirmed as treatment failures.
Anthony Waruru, Hellen Muttai, Lucy Ng’ang’a, Marta Ackers, Andrea Kim, Fredrick Miruka,Opiyo Erick, Julie Okonji, Tolbert Ayuaya, Sandra Schwarcz 2016, 'Positive Predictive Value of the WHO Clinical and Immunologic Criteria to PredictViral Load Failure among Adults on First, or Second-Line Antiretroviral Therapy inKenya', PLOS ONE10.1371/journal.pone.0158881. Retrieved from PLOS CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)
Of these, 255 participants (31.4%) had 263 virologically confirmed episodes of influenza.
Clotilde El Guerche-Séblain, Annick Moureau, Camille Schiffler, Martin Dupuy, StephaniePepin, Sandrine I. Samson, Philippe Vanhems, François Schellevis 2019, 'Epidemiology and burden of influenza in healthy children aged 6 to 35 months: analysisof data from the placebo arm of a phase III efficacy trial', BMC Infectious Diseaseshttp://link.springer.com/article/10.1186/s12879-019-3920-8. Retrieved from DOAJ CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)
The secondary outcome was virologic rebound in patients who were virologically suppressed at study entry.
Miguel Angel Luque-Fernandez, Gilles Van Cutsem, Eric Goemaere, Katherine Hilderbrand,Michael Schomaker, Nompumelelo Mantangana, Shaheed Mathee, Vuyiseka Dubula, NathanFord, Miguel A Hernán, Andrew Boulle 2013, 'Effectiveness of patient adherence groups as a model of care for stable patients onantiretroviral therapy in Khayelitsha, Cape Town, South Africa.', PLoS ONEhttp://europepmc.org/articles/PMC3571960?pdf=render. Retrieved from PLOS CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)
We estimated the proportion of virologically non-suppressed patients, and identified the factors associated with virological non-suppression.
Lilian Bulage, Isaac Ssewanyana, Victoria Nankabirwa, Fred Nsubuga, Christine Kihembo,Gerald Pande, Alex R. Ario, Joseph KB Matovu, Rhoda K. Wanyenze, Charles Kiyaga 2017, 'Factors Associated with Virological Non-suppression among HIV-Positive Patients onAntiretroviral Therapy in Uganda, August 2014–July 2015', BMC Infectious Diseaseshttp://link.springer.com/article/10.1186/s12879-017-2428-3. Retrieved from DOAJ CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)